Patents/Assignees

HANMI PHARM. CO., Ltd.

29 patents in portfolio

US12018060utility2024
Glucagon Derivatives
0 cites
US11925691utility2024
Non-peptidic Polymeric Linker Compound, Conjugate Comprising Same Linker Compound, and Methods for Preparing Same Linker Compound and Conjugate
0 cites
US11752216utility2023
Insulin Analog Complex with Reduced Affinity for Insulin Receptor and Use Thereof
0 cites
US11746137utility2023
Immunostimulating IL-2 Analogs
0 cites
US11717577utility2023
Method for Preparing Long-acting Drug Conjugate Through Preparation of Intermediate
0 cites
US11684655utility2023
Methods of Treating Neutorpenia Using G-CSF Protein Complex
0 cites
US11667688utility2023
Glucagon Derivative and a Composition Comprising a Long Acting Conjugate of the Same
0 cites
US11649246utility2023
Salts of 4-amino-n-(l-((3-chloro-2-fluorophenyl)amino)-6-methylisoquinolin-5-yl)thieno[3,2-d]pyrimidine-7-carboxamide, and Crystalline Forms Thereof
0 cites
US11603346utility2023
Polyethylene Glycol Derivative and Use Thereof
0 cites

← PreviousPage 2 of 2